Cargando…
Mesoporous silica nanoparticle-encapsulated Bifidobacterium attenuates brain Aβ burden and improves olfactory dysfunction of APP/PS1 mice by nasal delivery
BACKGROUND: Dysbiosis or imbalance of gut microbiota in Alzheimer's disease (AD) affects the production of short-chain fatty acids (SCFAs), whereas exogenous SCFAs supplementation exacerbates brain Aβ burden in APP/PS1 mice. Bifidobacterium is the main producer of SCFAs in the gut flora, but or...
Autores principales: | Liu, Ni, Yang, Changwen, Liang, Xiaohan, Cao, Kai, Xie, Jun, Luo, Qingming, Luo, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547428/ https://www.ncbi.nlm.nih.gov/pubmed/36207740 http://dx.doi.org/10.1186/s12951-022-01642-z |
Ejemplares similares
-
Dual-targeted magnetic mesoporous silica nanoparticles reduce brain amyloid-β burden via depolymerization and intestinal metabolism
por: Liu, Ni, et al.
Publicado: (2022) -
Dynamic Changes in the Levels of Amyloid-β(42) Species in the Brain and Periphery of APP/PS1 Mice and Their Significance for Alzheimer’s Disease
por: Zhang, Liding, et al.
Publicado: (2021) -
Mesoporous silica nanocarriers encapsulated antimalarials with high therapeutic performance
por: Amolegbe, Saliu Alao, et al.
Publicado: (2018) -
Encapsulation of drug into mesoporous silica by solvent evaporation: A comparative study of drug characterization in mesoporous silica with various molecular weights
por: Budiman, Arif, et al.
Publicado: (2021) -
Strategies to Obtain Encapsulation and Controlled Release of Pentamidine in Mesoporous Silica Nanoparticles
por: Peretti, Enrico, et al.
Publicado: (2018)